Abbott Laboratories - 37 Year Stock Price History | ABT

Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of August 10, 2020 is 100.04.
  • The all-time high Abbott Laboratories stock closing price was 102.52 on July 29, 2020.
  • The Abbott Laboratories 52-week high stock price is 102.89, which is 2.8% above the current share price.
  • The Abbott Laboratories 52-week low stock price is 61.61, which is 38.4% below the current share price.
  • The average Abbott Laboratories stock price for the last 52 weeks is 86.94.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Abbott Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 88.9131 86.9500 102.5200 62.8200 100.0400 15.17%
2019 80.5399 69.5000 88.7400 66.2200 86.8600 20.09%
2018 64.2198 58.7900 74.2700 56.2700 72.3300 26.74%
2017 48.5437 39.0500 57.4700 39.0500 57.0700 48.58%
2016 40.4946 42.9300 45.2900 36.3400 38.4100 -14.47%
2015 46.3063 44.9000 51.2000 39.0600 44.9100 -0.24%
2014 40.9592 38.2300 46.3700 35.8500 45.0200 17.45%
2013 35.6540 32.0500 38.7100 32.0500 38.3300 -41.48%
2012 62.7592 56.7200 72.1300 54.1500 65.5000 16.49%
2011 51.0656 47.8200 56.3300 45.1600 56.2300 17.37%
2010 50.7320 54.4600 56.2400 45.8600 47.9100 -11.26%
2009 48.4288 53.5600 57.2500 41.5200 53.9900 1.16%
2008 55.1625 55.8100 60.5000 49.4500 53.3700 -4.95%
2007 54.4193 48.9700 59.4300 48.9700 56.1500 15.27%
2006 45.0284 39.5500 49.4800 39.5500 48.7100 23.54%
2005 45.3700 46.6700 49.9900 37.6300 39.4300 -15.48%
2004 42.3562 46.7500 46.9900 38.3600 46.6500 0.11%
2003 41.2727 40.0500 47.1500 34.3800 46.6000 16.50%
2002 45.8684 55.8400 57.7000 31.0000 40.0000 -28.25%
2001 50.0663 48.1300 56.7700 42.0600 55.7500 15.09%
2000 41.6982 35.0000 55.7500 29.6300 48.4400 33.41%
1999 43.6333 48.7500 52.9400 33.3100 36.3100 -25.90%
1998 40.9077 33.7200 49.7500 33.3450 49.0000 49.62%
1997 30.8148 25.1900 34.3150 25.1900 32.7500 29.06%
1996 22.6483 20.8750 28.3750 19.3750 25.3750 21.91%
1995 19.2416 16.3150 22.3150 15.6250 20.8150 27.58%
1994 14.8357 14.4400 16.8150 13.0650 16.3150 10.12%
1993 13.4211 15.1900 15.1900 11.5000 14.8150 -2.47%
1992 15.3475 16.8125 17.0300 13.5000 15.1900 -11.78%
1991 13.0176 10.8125 17.2175 9.9375 17.2175 53.04%
1990 9.5320 8.6563 11.3750 7.8750 11.2500 32.35%
1989 7.3855 5.9688 8.7663 5.8288 8.5000 41.28%
1988 5.8545 6.0788 6.5000 5.3750 6.0163 -0.25%
1987 7.1870 5.9375 8.3600 5.3750 6.0313 5.74%
1986 5.4847 4.2500 6.7963 3.9844 5.7038 33.48%
1985 3.4075 2.5394 4.3831 2.5000 4.2731 63.76%
1984 2.6840 2.8750 3.0000 2.3750 2.6094 -7.73%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $177.124B $31.904B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $134.640B 21.87
Stryker (SYK) United States $70.344B 27.28
Boston Scientific (BSX) United States $55.768B 32.22
Lonza Group Ag (LZAGY) Switzerland $46.044B 0.00
Baxter (BAX) United States $42.068B 25.73
Terumo (TRUMY) Japan $28.809B 36.83
Zimmer Biomet Holdings (ZBH) United States $28.652B 23.78
EssilorLuxottica Societe Anonyme (ESLOY) France $28.072B 0.00
ResMed (RMD) United States $25.339B 36.80
Sunny Optical Technology (SNPTF) China $20.401B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.905B 0.00
Bio-Rad Laboratories (BIO) United States $15.045B 68.05
Insulet (PODD) United States $13.389B 566.50
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.636B 51.04
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.061B 12.12
Canopy Growth (CGC) Canada $6.650B 0.00
Hill-Rom Holdings (HRC) United States $6.384B 15.84
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.311B 0.00
Neogen (NEOG) United States $4.168B 69.64
Haemonetics (HAE) United States $4.002B 26.67
ICU Medical (ICUI) United States $3.727B 28.58
Envista Holdings (NVST) United States $3.647B 24.87
Abcam (ABCZY) $3.548B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.538B 0.00
Agios Pharmaceuticals (AGIO) United States $2.913B 0.00
National Vision Holdings (EYE) United States $2.828B 439.63
NuVasive (NUVA) United States $2.699B 37.62
TG Therapeutics (TGTX) United States $2.058B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.013B 185.38
AtriCure (ATRC) United States $1.896B 0.00
MacroGenics (MGNX) United States $1.504B 0.00
Aphria (APHA) Canada $1.333B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aurora Cannabis (ACB) Canada $1.180B 0.00
Cerus (CERS) United States $1.172B 0.00
Omeros (OMER) United States $1.162B 0.00
Cardiovascular Systems (CSII) United States $1.092B 0.00
OraSure Technologies (OSUR) United States $1.041B 0.00
InMode (INMD) Israel $0.989B 24.94
Quanterix (QTRX) United States $0.945B 0.00
Lantheus Holdings (LNTH) United States $0.919B 12.73
Owens & Minor (OMI) United States $0.878B 19.67
PetIQ (PETQ) United States $0.877B 25.32
Phibro Animal Health (PAHC) United States $0.816B 16.26
Meridian Bioscience (VIVO) United States $0.791B 18.27
Vapotherm (VAPO) United States $0.743B 0.00
BioLife Solutions (BLFS) United States $0.721B 376.17
VAREX IMAGING (VREX) United States $0.649B 16.12
Surmodics (SRDX) United States $0.643B 70.52
Zynex (ZYXI) United States $0.628B 54.82
LeMaitre Vascular (LMAT) United States $0.602B 36.74
Eagle Pharmaceuticals (EGRX) United States $0.592B 83.19
Cytosorbents (CTSO) United States $0.407B 0.00
Viemed Healthcare (VMD) United States $0.404B 14.44
Neptune Wellness Solutions (NEPT) Canada $0.339B 0.00
HEXO (HEXO) $0.333B 0.00
Utah Medical Products (UTMD) $0.293B 25.16
InfuSystems Holdings (INFU) United States $0.270B 149.44
Organigram Holdings (OGI) Canada $0.235B 0.00
Female Health (VERU) United States $0.214B 0.00
Chimerix (CMRX) United States $0.201B 0.00
Bovie Medical (APYX) United States $0.176B 0.00
Exagen (XGN) United States $0.170B 0.00
Surface Oncology (SURF) United States $0.168B 0.00
Fonar (FONR) United States $0.168B 14.88
Wound Management Technologies (SMTI) United States $0.166B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.133B 0.00
Liberty Health Sciences (LHSIF) Canada $0.126B 0.00
Evolus (EOLS) United States $0.125B 0.00
Rockwell Medical (RMTI) United States $0.119B 0.00
Chembio Diagnostics (CEMI) United States $0.115B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Capricor Therapeutics (CAPR) United States $0.087B 0.00
MTech Acquisition (KERN) United States $0.086B 0.00
United-Guardian (UG) United States $0.071B 15.88
Nephros (NEPH) United States $0.068B 0.00
Brainsway (BWAY) Israel $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Akers Biosciences Inc (AKER) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.038B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00